Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 1,033 | 1,095 | 41,439 | 954 | 1,628 |
| Gross Profit | 1,033 | 1,095 | 41,439 | 954 | 1,628 |
| Operating Expenses | 84,175 | 76,603 | 70,906 | 59,865 | 51,721 |
| Operating Income | -83,142 | -75,508 | -29,467 | -58,911 | -50,093 |
| Interest Expense | 0 | 14 | 23 | 32 | 0 |
| Other Income | 2,820 | 2,799 | 2,442 | 2,394 | 1,066 |
| Pre-tax Income | -80,322 | -72,723 | -27,048 | -56,549 | -49,027 |
| Net Income Continuous | -80,322 | -72,723 | -27,048 | -56,549 | -49,027 |
| Net Income | $-80,322 | $-72,723 | $-27,048 | $-56,549 | $-49,027 |
| EPS Basic Total Ops | -1.82 | -1.66 | -0.62 | -1.29 | -1.26 |
| EPS Basic Continuous Ops | -1.83 | -1.66 | -0.62 | -1.29 | -1.25 |
| EPS Diluted Total Ops | -1.82 | -1.66 | -0.62 | -1.29 | -1.26 |
| EPS Diluted Continuous Ops | -1.83 | -1.66 | -0.62 | -1.29 | -1.25 |
| EBITDA(a) | $-83,419 | $-75,604 | $-29,317 | $-58,823 | $-49,988 |